Pharmacy Blogs

Endo names ex-Nora Therapeutics CEO as COO The Associated Press Endo Pharmaceuticals is a specialty pharmaceutical company involved with drugs used to treat and manage pain, prostate cancer and the early onset of puberty … Endo Pharmaceuticals Announces Appointment of New Chief Operating OfficerPR Newswire (press release) all 106 news articles »

Endo names ex-Nora Therapeutics CEO as COO – The Associated Press

Times Online

Torrent Pharmaceuticals signs license agreement with AstraZeneca Stock Watch Torrent Pharmaceuticals has singed a supply and licensing agreement with the UK based drug maker AstraZeneca. AstraZeneca, a $32.8-billion enterprise, … AstraZeneca ties up with Indian drugmakerFinancial Times AstraZeneca teams with generic firmThe News Journal The Next Big Opportunity for Big Pharma Is BRICMinyanville.com NASDAQ -Calcutta Telegraph -domain-B all 159 news articles »

Torrent Pharmaceuticals signs license agreement with AstraZeneca – Stock Watch

Times Online

Torrent Pharmaceuticals signs license agreement with AstraZeneca Stock Watch Torrent Pharmaceuticals has singed a supply and licensing agreement with the UK based drug maker AstraZeneca. AstraZeneca, a $32.8-billion enterprise, … AstraZeneca ties up with Indian drugmakerFinancial Times AstraZeneca teams with generic firmThe News Journal The Next Big Opportunity for Big Pharma Is BRICMinyanville.com NASDAQ -Calcutta Telegraph -domain-B all 159 news articles »

Torrent Pharmaceuticals signs license agreement with AstraZeneca – Stock Watch

Times Online

Torrent Pharmaceuticals signs license agreement with AstraZeneca Stock Watch Torrent Pharmaceuticals has singed a supply and licensing agreement with the UK based drug maker AstraZeneca. AstraZeneca, a $32.8-billion enterprise, … AstraZeneca ties up with Indian drugmakerFinancial Times AstraZeneca teams with generic firmThe News Journal The Next Big Opportunity for Big Pharma Is BRICMinyanville.com NASDAQ -Calcutta Telegraph -domain-B all 159 news articles »

Torrent Pharmaceuticals signs license agreement with AstraZeneca – Stock Watch

Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin Trading Markets (press release) Generic pharmaceuticals provider Caraco Pharmaceutical Laboratories Ltd (NYSE: CPD | Quote | Chart | News | PowerRating) said on Thursday that the company … Caraco launches colon, rectal cancer genericDrug Store News Caraco gets FDA approval for generic EloxatinThe Associated Press Sun Pharma unit Caraco launches anti-cancer drug in USEconomic Times PR Newswire (press release) -Press Trust of India -ONN.tv all 101 news articles »

Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin – Trading Markets (press release)

Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin Trading Markets (press release) Generic pharmaceuticals provider Caraco Pharmaceutical Laboratories Ltd (NYSE: CPD | Quote | Chart | News | PowerRating) said on Thursday that the company … Caraco launches colon, rectal cancer genericDrug Store News Caraco gets FDA approval for generic EloxatinThe Associated Press Sun Pharma unit Caraco launches anti-cancer drug in USEconomic Times PR Newswire (press release) -Press Trust of India -ONN.tv all 101 news articles »

Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin – Trading Markets (press release)

Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin Trading Markets (press release) Generic pharmaceuticals provider Caraco Pharmaceutical Laboratories Ltd (NYSE: CPD | Quote | Chart | News | PowerRating) said on Thursday that the company … Caraco launches colon, rectal cancer genericDrug Store News Caraco gets FDA approval for generic EloxatinThe Associated Press Sun Pharma unit Caraco launches anti-cancer drug in USEconomic Times PR Newswire (press release) -Press Trust of India -ONN.tv all 101 news articles »

Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin – Trading Markets (press release)

drug Sutent failed to meet their goals and it has stopped a pivotal lung cancer trial of an experimental drug. Pfizer said outside monitors concluded …
Setbacks for Pfizer on Cancer Treatments

drug Sutent failed to meet their goals and it has stopped a pivotal lung cancer trial of an experimental drug. Pfizer said outside monitors concluded …
Setbacks for Pfizer on Cancer Treatments

drug Sutent failed to meet their goals and it has stopped a pivotal lung cancer trial of an experimental drug. Pfizer said outside monitors concluded …
Setbacks for Pfizer on Cancer Treatments